Please try another search
For the nine months ended 30 September 2018, Imperva Inc revenues increased 13% to $260.7M. Net loss before extraordinary items totaled $32M vs. income of $19.2M. Revenues reflect Asia Pacific segment increase of 28% to $60.1M, EMEA segment increase of 21% to $53.8M. Net loss reflects Gain on sale of business decrease from $35.9M (income) to $0K, Other Research and development increase of 30% to $48.9M (expense).
Period Ending: | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 |
---|---|---|---|---|
Total Revenue | 91.63 | 84.8 | 84.24 | 91.08 |
Gross Profit | 72.65 | 67.37 | 65.4 | 74.22 |
Operating Income | 0.47 | -4.37 | -11.24 | 2.83 |
Net Income | 1.06 | -23.06 | -9.78 | 3.65 |
Period Ending: | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 |
---|---|---|---|---|
Total Assets | 605.94 | 574.49 | 549.11 | 528.06 |
Total Liabilities | 264.32 | 246.05 | 210.84 | 212.94 |
Total Equity | 341.62 | 328.44 | 338.26 | 315.12 |
Period Ending: | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | 68.58 | 36.33 | 22.5 | 67.16 |
Cash From Investing Activities | -105.83 | -22.09 | -0.34 | 7.29 |
Cash From Financing Activities | 1.65 | 3.24 | -0.38 | 9.45 |
Net Change in Cash | -36.31 | 16.68 | 21.78 | 85.19 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review